Between Comfort and Caution: A Study Challenges Assumptions About Sanitary Pads

In the late afternoon bustle of Johannesburg, pharmacy shelves stand neatly arranged — rows of pastel boxes promising comfort, discretion, protection. For millions of women, these products are part of an ordinary monthly rhythm, purchased without hesitation, trusted without question. Yet this week, that quiet trust has been unsettled by new findings that have stirred concern and conversation across South Africa.

A recent study conducted by researchers at the University of the Free State has identified the presence of hormone-disrupting chemicals in several brands of sanitary pads and pantyliners marketed as safe. The research, which examined commonly available products, has raised questions about ingredient transparency and long-term exposure risks.

In response, menstrual health rights activist Nokuzola Ndwandwe has urged women to exercise caution and to stop using products they believe may be unsafe. She advised that any persistent irritation, discomfort, or unusual symptoms should not be dismissed as routine. Instead, she encourages consumers to seek medical advice and to report concerns where necessary.

Endocrine-disrupting chemicals, often referred to as hormone disruptors, are substances that can interfere with the body’s hormonal system. In certain contexts, prolonged exposure has been associated with reproductive health issues, developmental concerns, and other physiological effects. The degree of risk depends on concentration levels, frequency of exposure, and individual sensitivity — factors that researchers continue to examine carefully.

The University of the Free State team reportedly tested multiple brands widely sold in South African retail outlets. While the study does not constitute a regulatory ruling, it has prompted calls for clearer labeling standards and independent product assessments. Advocacy groups argue that menstrual products, used repeatedly and often for extended periods, warrant the same scrutiny applied to other health-related goods.

Manufacturers have not universally responded in detail to the findings, though industry representatives have historically maintained that products placed on shelves comply with existing safety regulations. In South Africa, oversight of consumer goods involves multiple agencies, and enforcement standards vary depending on classification.

The issue touches on more than chemistry. Access to safe menstrual products has long been framed as a matter of dignity and equity. In recent years, public initiatives have sought to expand availability in schools and low-income communities. Any suggestion that commonly used items may pose health concerns introduces a new layer of complexity to that effort.

Ndwandwe has emphasized that awareness, rather than alarm, should guide public reaction. She encourages women to stay informed, monitor how their bodies respond, and consult healthcare providers if necessary. Her message reflects a broader principle within health advocacy: informed choice begins with accessible information.

For now, the study’s findings are likely to fuel further testing, regulatory review, and public discussion. In laboratories and policy offices, data will be analyzed and debated. On store shelves, the boxes remain, familiar in appearance yet newly scrutinized.

Sometimes change begins quietly — not with sweeping legislation, but with a single study and a question about what we consider safe. As conversations continue, many women will be looking not only for reassurance, but for clarity.

AI Image Disclaimer Illustrations were created using AI tools and are not real photographs.